US4053626A
(en)
*
|
1973-03-13 |
1977-10-11 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
Cholesterol level-lowering phenoxyacetic acids
|
NZ252051A
(en)
*
|
1992-05-19 |
1996-10-28 |
Graham Edmund Kelly |
Health supplement comprising a phyto-oestrogen selected from genistein, daidzein, biochanin and/or formononetin
|
US5446061A
(en)
*
|
1993-11-05 |
1995-08-29 |
Eli Lilly And Company |
Methods for lowering serum cholesterol
|
US5407955A
(en)
*
|
1994-02-18 |
1995-04-18 |
Eli Lilly And Company |
Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease
|
US5446071A
(en)
*
|
1994-11-18 |
1995-08-29 |
Eli Lilly And Company |
Methods for lowering serum cholesterol
|
CA2208859A1
(en)
*
|
1995-01-13 |
1996-07-18 |
Novo Nordisk A/S |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis or for anticoagulative treatment
|
AUPO203996A0
(en)
*
|
1996-08-30 |
1996-09-26 |
Novogen Research Pty Ltd |
Therapeutic uses
|
CA2270055A1
(en)
*
|
1996-10-28 |
1998-05-07 |
Novo Nordisk A/S |
Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
US6043269A
(en)
*
|
1996-10-28 |
2000-03-28 |
Novo Nordisk A/S |
cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
US5985306A
(en)
*
|
1996-10-28 |
1999-11-16 |
Novo Nordisk A/S |
(+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes
|
US6316494B1
(en)
|
1996-10-28 |
2001-11-13 |
Novo Nordisk A/S |
cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
IL129627A0
(en)
*
|
1996-10-28 |
2000-02-29 |
Novo Nordisk As |
Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
CA2270113A1
(en)
*
|
1996-10-28 |
1998-05-07 |
Poul Jacobsen |
Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
JP2001502706A
(ja)
*
|
1996-10-28 |
2001-02-27 |
ノボ ノルディスク アクティーゼルスカブ |
エストロゲン関連病あるいは症候群の予防または治療に有用な新規トランス―3,4クロマン誘導体
|
ZA979647B
(en)
*
|
1996-10-28 |
1998-04-28 |
Novo Nordisk As |
Heterocyclic compounds, compositions and uses.
|
US5958967A
(en)
*
|
1996-10-28 |
1999-09-28 |
Novo Nordisk A/S |
Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
US5994390A
(en)
*
|
1996-10-28 |
1999-11-30 |
Novo Nordisk |
Trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
AU4699997A
(en)
*
|
1996-10-28 |
1998-05-22 |
Novo Nordisk A/S |
Novel (cis)-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
IL129618A0
(en)
*
|
1996-10-28 |
2000-02-29 |
Novo Nordisk As |
Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
US5919817A
(en)
*
|
1996-10-28 |
1999-07-06 |
Novo Nordisk A/S |
Cis-3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
ATE231141T1
(de)
*
|
1996-10-28 |
2003-02-15 |
Novo Nordisk As |
(-)-enantiomere von cis-3,4-chromanderivaten zur vorbeugung oder behandlungvon oestrogenbezogenen krankheiten oder syndromen
|
ZA979644B
(en)
*
|
1996-10-28 |
1998-04-28 |
Novo Nordisk As |
Heterocyclic compounds, compositions and uses.
|
US6146668A
(en)
|
1997-04-28 |
2000-11-14 |
Novogen, Inc. |
Preparation of isoflavones from legumes
|
CA2287965C
(en)
*
|
1997-05-01 |
2009-10-20 |
Graham Edmund Kelly |
Treatment or prevention of menopausal symptoms and osteoporosis
|
AUPP112497A0
(en)
*
|
1997-12-24 |
1998-01-22 |
Novogen Research Pty Ltd |
Compositions and method for protecting skin from UV induced immunosupression and skin damage
|
AUPP260798A0
(en)
|
1998-03-26 |
1998-04-23 |
Novogen Research Pty Ltd |
Treatment of medical related conditions with isoflavone containing extracts of clover
|
KR20000001793A
(ko)
*
|
1998-06-13 |
2000-01-15 |
이경하 |
신규한 벤조피란 또는 티오벤조피란 유도체
|
AUPP868599A0
(en)
*
|
1999-02-15 |
1999-03-11 |
Novogen Research Pty Ltd |
Production of isoflavone derivatives
|
US20090233999A1
(en)
*
|
1999-09-06 |
2009-09-17 |
Novogen Research Pty Ltd |
Compositions and therapeutic methods involving isoflavones and analogues thereof
|
AUPQ266199A0
(en)
*
|
1999-09-06 |
1999-09-30 |
Novogen Research Pty Ltd |
Compositions and therapeutic methods involving isoflavones and analogues thereof
|
AUPQ520300A0
(en)
*
|
2000-01-21 |
2000-02-17 |
Novogen Research Pty Ltd |
Food product and process
|
AU2001256164A1
(en)
|
2000-03-01 |
2001-09-12 |
Akzo Nobel N.V. |
Chroman derivatives as estrogenic compounds
|
AUPR363301A0
(en)
*
|
2001-03-08 |
2001-04-05 |
Novogen Research Pty Ltd |
Dimeric isoflavones
|
US20050119301A1
(en)
*
|
2001-03-16 |
2005-06-02 |
Alan Husband |
Treatment of restenosis
|
JP2007511542A
(ja)
*
|
2003-11-18 |
2007-05-10 |
ノボゲン リサーチ ピーティーワイ リミテッド |
イソフラボノイドプロドラッグ、その組成物、それらを使用する治療法
|
AU2004290613B2
(en)
*
|
2003-11-18 |
2010-03-25 |
Novogen Research Pty Ltd |
Isoflavonoid prodrugs, compositions thereof and therapeutic methods involving same
|
US8080675B2
(en)
*
|
2004-09-21 |
2011-12-20 |
Marshall Edwards, Inc. |
Chroman derivatives, medicaments and use in therapy
|
ATE532777T1
(de)
|
2004-09-21 |
2011-11-15 |
Marshall Edwards Inc |
Substituierte chromanderivate, medikamente und anwendungen in der therapie
|
CA2816322A1
(en)
|
2010-11-01 |
2012-05-10 |
Marshall Edwards, Inc. |
Isoflavonoid compositions and methods for the treatment of cancer
|
AU2016215515B2
(en)
|
2015-02-02 |
2020-04-30 |
Mei Pharma, Inc. |
Combination therapies
|